Navigation Links
MDS Nordion Submits Expression of Interest Proposal to Government of Canada on Medical Isotope and Generator Production
Date:7/30/2009

MAPLE Reactors Could Solve the Isotope Crisis within 24 months

OTTAWA, July 30 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has submitted a Proposal to the Government of Canada's Expert Review Panel on Medical Isotope and Technetium-99m (Tc-99m) Generator Production. MDS Nordion believes that the best answer to the shortage of medical radioisotopes is the completion and bringing into service of the MAPLE project. The MDS Nordion Proposal outlines technical and regulatory requirements needed for the provision of a secure supply of medical isotopes for the health care system in Canada and around the world.

With no domestic or international sources of supply that can fully mitigate the current global shortage of medical isotopes, MDS Nordion urges Atomic Energy of Canada Limited (AECL) to complete the MAPLE project to address this shortage. With expertise and guidance from the South African Nuclear Energy Corporation (Necsa), owner and operator of the SAFARI-1 reactor, and working with AECL, MDS Nordion believes a solution could be achieved in an estimated 24 months.

"MDS Nordion is a solutions oriented Company with strong technical and regulatory expertise. We look forward to working with Necsa on the next stages of this proposal," said Steve West, President of MDS Nordion. "We believe this approach provides a good path forward to bring the MAPLEs into service and provide a long-term supply of medical isotopes for Canadians. This goal is of utmost importance and we are also supportive of other proposals which may provide this critical supply."

Project Description

MDS Nordion urges AECL to honour its long-standing commitment to replace the National Research Universal (NRU) by bringing the MAPLE facilities into service. This can be done through AECL collaborating with Necsa on the adaption of the OSCAR computer codes, which are successfully
'/>"/>

SOURCE MDS Nordion
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MDS Nordion signs 17-year contract with Rosenergoatom
2. MDS Nordion Divests Non Strategic Product Lines
3. MDS Nordion Provides Update to Medical Isotope Customers
4. Dr. Peter Covitz Joins MDS Nordion as Senior Vice-President Innovation
5. MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians
6. MDS Nordion Provides Update on AECLs Medical Isotope Supply Disruption
7. MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium
8. MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage
9. MDS Nordion Begins to Manufacture Cardiac Imaging Agent
10. MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage
11. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ation of arsenic compounds appears to cause oxidat...ty, according to a new study published online Nove...titute . , Although biomethylation was once beli...ght to enhance its toxicity and potentially its ca... biomethylation in oxidative DNA damage in mice, M...
(Date:11/23/2009)...(Nov. 23, 2009) -- A first-of-its-kind consensus s...oday in the Annals of Surgery . The report illust...ensus conference -- Diabetes Surgery Summit (DSS) ...ientific and medical experts agreed on a set of ev...eant to guide the use and study of gastrointestina...
(Date:11/23/2009)...ne Healy, first woman to head the agency, said liv...(HealthDay News) -- The fallout from last week,s c...tart of routine mammogram testing for breast cance...al Institutes of Health advising women to ignore t...nore them, because unequivocally this will increas...
(Date:11/23/2009)...rtnershipswithMinorityBanksin Washington D.C. ...d Columbia , S.C. IntendedtoSpurEconomicGrowth...ire-USNewswire/--DaVita,thenation,sleadingprovider...tyBankInitiativedesignedtocreatejobsandspurrevital...vestmentsinleadingcommunityandminority-ownedbanks....
(Date:11/23/2009)...HINGTON,Nov.23/PRNewswire-USNewswire/-- The Ameri...rgestindividualmembershipassociationofstatelegisla...eTimScott forpre-filinga constitutionalamendment t...arechoices.SouthCarolinanowbecomesthe24thstatewher...tionmodeledafterALEC,s FreedomofChoiceinHealthCare...
Breaking Medicine News(10 mins):Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:South Carolina Now 24th State to Defend Health Care Choice 2
...d be promising news in the quest to find a therapy...lerosis (ALS), or Lou Gehrigs disease, scientists ...School of Medicine have shown that targeting neuro... Professor of Medicine, Neurosciences and Cellular...
...adio Network, BOSTON, Feb. 2 While the Patriots ...sachusetts healthcare workers,will take on the hos...ly in,fair secret ballot elections to form unions....g jobs for working families., As a Super Bowl and...
... immigrants, minorities, poor thwart reaching 2010... News) -- It appears that the United States will f...ating tuberculosis, according to an analysis of Na...2000 was 4.2 percent. This does not include homele...
...can Heart Month, a,time when experts say we need t...risk for heart disease. Here,s more on how you may...at the right kind for good heart health., Listen ...ts can access video, audio, text, graphics and,pho...
... for fetal growth restriction, preterm birth , ...regnancy, asthmatic women should continue to use t... to manage symptoms. , So recommends a new Practic...hould also be monitored throughout pregnancy for f...
...asers Ltd. ("Alma,Lasers"), a global developer and...frequency-based aesthetic devices, announced today... Annual Meeting of the American Academy,of Dermato...ne of products in booth #4465 at the Henry B. Gonz...
Other Medicine News:Health News:Targeting astrocytes slows disease progression in ALS 2Health News:SEIU Healthcare Workers to Appeal During Super Bowl for Free and Fair Union Elections in Boston Hospitals 2Health News:U.S. Unlikely to Meet Target for TB Elimination 2Health News:Pregnant Women With Asthma Should Stay on Low Dose of Meds 2Health News:Alma(TM) Lasers to Debut Five New Products at the 66th Annual Meeting of the American Academy of Dermatology 2
(Date:11/23/2009)...swire/--BioTrendsResearchGroup,Inc.releasedWave2of...ndinamulti-phasesyndicatedmarketresearchprojecttra...roughthefirstsixmonthsofproductavailability.Eachwa...uniqueNephrologistsandqualitativeinformationfromas...staclestouse,reasonstouse,typicalpatienttypes,prod...
(Date:11/23/2009)...Newswire/--AMDLASERSannouncedthisweekthatitcontinu...ringwithprestigiousindustry-leaderDr.LarryRosentha...heexclusivesofttissuediodelaserusedduringallintern...top2%ofdentists. ,, (Photo: http://www.newscom....hgreatpleasurethatIproudlyannounceourpartnership.S...
(Date:11/23/2009)...RNewswire-FirstCall/--RaptorPharmaceuticalCorp.("R...thepresentationofclinicaltrialdataonNGX426,theComp...eptorantagonist,atthe12thInternationalConferenceon...ovember20-21inSanFrancisco.Theresultsofthestudyled...gyattheCenterforPainMedicineoftheUniversityofCalif...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Shifting baselines confound river restoration 9746 1Shifting baselines confound river restoration 9746 2DaVita CEO Kent Thiry Honored as One of Modern Healthcares 100 Most Powerful People in Healthcare 55783 1DaVita CEO Kent Thiry Honored as One of Modern Healthcares 100 Most Powerful People in Healthcare 55783 2Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21 2009 55779 1Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21 2009 55779 2
...--Jun 11, 2007 - Neurogen,Corporation (Nasdaq: NRG... clinical studies for NG2-73, the Company,s lead c...ted today at the SLEEP,2007 Annual Meeting of the ...Minneapolis, Minnesota. Two Phase 2b clinical stud...urrently being,conducted by the Company. Data pres...
...EGEVILLE, Pa.--(BUSINESS WIRE)--Jun,13, 2007 - Amg...sion of Wyeth (NYSE:WYE), today announced the pres...afety profile of Enbrel(R),(etanercept) was mainta...to-severe juvenile rheumatoid arthritis (JRA) who,...hronic autoimmune,disease of childhood that is som...
Other Medicine Technology:Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 4Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 2Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 3Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 4Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 5Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 6Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 7Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 8
Sugita Aneurysm Clip J-Shaped (M)
Sugita Aneurysm Clip 1/4 Cvd. (L)
Sugita Aneurysm Clip 45 Angled (L)
Sugita Aneurysm Clip L-Shaped (S)
Medicine Products: